Steven Cohen Entera Bio Ltd. Transaction History
Point72 Asset Management, L.P.
- $51 Billion
- Q3 2025
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Entera Bio Ltd. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 1,178,443 shares of ENTX stock, worth $3.19 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,178,443
Previous 2,697,236
56.31%
Holding current value
$3.19 Million
Previous $5.12 Million
56.09%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding ENTX
# of Institutions
25Shares Held
9.21MCall Options Held
21.1KPut Options Held
0-
Knoll Capital Management, LLC Miami, FL5.88MShares$15.9 Million6.34% of portfolio
-
Marshall Wace, LLP London, X0627KShares$1.7 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY567KShares$1.54 Million0.01% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT281KShares$761,0270.07% of portfolio
-
Northern Trust Corp Chicago, IL149KShares$402,8900.0% of portfolio
About Entera Bio Ltd.
- Ticker ENTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,809,900
- Market Cap $78.1M
- Description
- Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...